![](/img/cover-not-exists.png)
Trough plasma concentration of imatinib reflects BCR–ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia: A report from the BINGO study
Yuichi Ishikawa, Hitoshi Kiyoi, Keisuke Watanabe, Koichi Miyamura, Yasuyuki Nakano, Kunio Kitamura, Akio Kohno, Isamu Sugiura, Toshiya Yokozawa, Akitoshi Hanamura, Kazuhito Yamamoto, Hiroatsu Iida, NoVolume:
101
Year:
2010
Language:
english
Pages:
7
DOI:
10.1111/j.1349-7006.2010.01643.x
File:
PDF, 374 KB
english, 2010